Ghost Tree Capital, LLC Krystal Biotech, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$153.12 - $183.64 $842,160 - $1.01 Million	-5,500 Reduced 39.29%	8,500 $1.56 Million
Q1 2024 May 15, 2024	SELL	$108.01 - $179.35 $3.89 Million - $6.46 Million	-36,000 Reduced 72.0%	14,000 $2.49 Million
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $2.88 Million - $3.85 Million	-30,000 Reduced 37.5%	50,000 $6.2 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $6.51 Million - $7.81 Million	60,000 Added 300.0%	80,000 $9.28 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $1.57 Million - $2.61 Million	20,000 New	20,000 $2.35 Million

311

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.07B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.